Author | Bruce D. Cheson, MD

Articles

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma

January 15, 2017

Here we critically analyze the role of PET/CT in the early assessment of Hodgkin lymphoma.

FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation

January 15, 2017

Here we review the role of interim PET/CT in diffuse large B-cell lymphoma (DLBCL), and also explore the question of whether new approaches to quantitative assessment improve the prognostic value of interim PET scans in both Hodgkin lymphoma and DLBCL.

Small Molecules, Big Challenges

April 15, 2015

With each passing year, chemotherapy is less and less a focus of interest. Instead, the focus is on the abundance of exciting new biologic and targeted agents that are bulldozing the therapeutic landscape in the lymphomas and chronic lymphocytic leukemia.